Kinnate Biopharma Q2 EPS $(0.62) Down From $(0.49) YoY

Kinnate Biopharma (NASDAQ:KNTE) reported quarterly losses of $(0.62) per share. This is a 26.53 percent decrease over losses of $(0.49) per share from the same period last year.

byBenzinga Newsdesk

August 11, 2022

1 minute read

Kinnate Biopharma (NASDAQ:KNTE) reported quarterly losses of $(0.62) per share. This is a 26.53 percent decrease over losses of $(0.49) per share from the same period last year.

Legal
News

‘Coinbase Employees And Ethereum Backers Sue U.s. Treasury Over Tornado Cash Sanctions’ – Fortune

By Benzinga Newsdesk

Today, 7:43 PM

Six users of Tornado Cash, a popular decentralized cryptocurrency service, filed a lawsuit on Thursday against the U.S. Treasury Department, Secretary Janet Yellen, and other officials over their decision to slap

COIN

Bowman Consulting Group Q1 EPS $0.12 Down From $0.17 YoY, Gross Contract Sales $52.46M Beat $45.51M Estimate; Raises Guidance

By Benzinga Newsdesk

Today, 7:43 PM

Bowman Consulting Group (NASDAQ:BWMN) reported quarterly earnings of $0.12 per share. This is a 29.41 percent decrease over earnings of $0.17 per share from the same period last year. The company reported quarterly

BWMN